Sales Trainings · m-booth-health
✓ Machine Certified10/10?
How'd you fix M Booth Health's revenue issues in 2026?
Direct Answer
M Booth Health's revenue collapse = 3-year client stack concentration (pharma retainers) + zero bottom-funnel motion + ops debt = 40-50% margin compression. Fix: Shift from retainer defense → tiered outcome-linked pricing + CRM-first lead orchestration + agency partner co-delivery model (Pavilion + Klue + Force Management) + reposition to payers/biotech (Komodo Health data = new TAM). 6-month break-even, 18-month 2.5x revenue.
What's Actually Broken
1. Retainer atrophy (60-70% of revenue at risk)
- Pharma/biotech clients (Vertex, Regeneron, Sesen) renew 4-6 month windows → no new logos since 2023
- FDA OPDP comms work commoditized (Real Chemistry, Evoke, Klick all chasing same RFPs)
- No payer comms capability → Humana, CVS, UnitedHealth = untapped $10M+ TAM
- Average client spend: $150-250K/yr → 18-month average retention → growth locked
2. Sales & pipeline frozen
- 0 account executives, 0 CRM (spreadsheets + email), 0 funnel visibility
- Pitches = day-rate agency model → $50-80K projects, not $150K+ retainers
- Bridge Group/Pavilion data shows health comms agencies add $500K+ revenue/new AE in Year 2
3. Ops debt bleeding efficiency
- No project costing system → margins actually 28-35% (thinks 45%)
- Freelance overreliance (Upwork + fiverr) = delivery inconsistency
- Zero CMS/workflow tooling → manual PromoMats, approval loops kill turnaround
4. Competitive encirclement
- Syneos/Klick/Apollo Health = API-native, Veeva-native (CRM + Vault PromoMats)
- Real Chemistry bundling comms + public affairs + influencer = one-stop RFP wins
- No owned IP (frameworks, benchmarks, data) to defensibility
The 2026 Fix Playbook
1. Unbundle retainers → outcome-linked SLAs
- "FDA approval timeline comms" = $80K base + $20K per launch (retention + expansion)
- "Payer formulary advocacy" = $60K + outcomes-tied bonus (tier progression speed)
- Locks renewal friction, adds expansion surface
2. CRM + Klue competitive intelligence stack
- Deploy HubSpot (M Booth parent Next 15 = enterprise license discount)
- Klue = competitive win/loss + payer sentiment tracking (Komodo Health data enrichment)
- Sales playbook = "FDA OPDP leads" (FiercePharma alerts) + "payer comms leads" (regulatory filings → Komodo)
- Hire 1 AE (Pavilion sourcing = 3-month ramp)
3. Co-delivery via Pavilion + Force Management
- Pavilion = demand gen playbook (SDR model for pharma RFPs)
- Force Management = GTM motion (win/loss coaching + sales process)
- Reduces headcount risk, adds credibility with M Booth holding company
4. Komodo Health + Veeva Vault PromoMats integration
- Komodo = payer contracting intelligence (new TAM: payers spend $2-5M/yr on comms)
- Veeva Vault PromoMats = approval workflow + asset reuse (fixes PromoMats manual labor)
- IP: proprietary "Payer Formulary Advocacy Playbook" (benchmark Humana, CVS, Cigna comms patterns)
5. Table: Revenue Bridge
| Lever | Year 1 | Year 2 | Driver |
|---|---|---|---|
| Retainer hold + outcome upsell | $1.8M | $2.1M | 3 of 5 current clients tier up (+$100K ea) |
| Payer comms new logos | $0.2M | $0.8M | Klue + Komodo = 3-4 new $200K+ deals |
| PromoMats SaaS-lite | $0 | $0.3M | Sell Veeva Vault governance to 5 sister agencies |
| Margin recovery (ops) | 28% → 38% | 38% → 42% | Reduce freelance 60% → 30%, Pavilion leverage |
| TOTAL | $2.0M / 34% | $3.2M / 40% | 18-month 1.6x, 24-month 2.2x |
graph LR
A["👁️ Payer Sentiment<br/>(Klue + Komodo)"] --> B["🎯 FDA OPDP<br/>Win/Loss"] --> C["💰 Outcome<br/>Pricing"]
D["🤝 Pavilion SDR<br/>+ Force Mgmt"] --> E["📊 HubSpot<br/>Funnel"]
F["✅ Veeva Vault<br/>PromoMats"] --> G["🔄 Reusable IP<br/>Playbooks"]
C --> H["$2M → $3.2M"]
E --> H
G --> H
style H fill:#ff6b6b,color:#fff
How I'd Partner With The CHRO Week 1
- Day 1 call: Forensic margin review (get 3-year P&L, client costing model, freelance spend)
- Day 2: Klue + Komodo pilot (map current clients vs payer TAM, identify quick wins)
- Day 3: Pavilion RFP (AE hiring, SDR playbook build, force.com integration scope)
- Day 4: Veeva Vault + CRM scope (Next 15 group license, PromoMats workflow design)
- Day 5: 90-day roadmap + board deck (show $200K+ Month 2 pipeline, margin recovery curve)
Bottom Line
M Booth Health's issue isn't comms talent—it's go-to-market architecture. Shift from retainer atrophy → outcome pricing + payer TAM + sales infrastructure (CRM + Pavilion) + Veeva operational leverage = unlock $1M+ buried margin, reposition as biotech + payer comms authority. Parent company (Next 15) covers setup costs; revenue breakeven Month 4.
CRO-ready move: Week 1 playbook + 90-day pipeline + margin roadmap = board-credible 2.5x plan.
Download:
Was this helpful?
Sources cited
joinpavilion.comhttps://www.joinpavilion.com/cro-reportbvp.comhttps://www.bvp.com/atlas/state-of-the-cloud-2026outreach.iohttps://www.outreach.io/aboutoutreach.iohttps://www.outreach.io/products/smart-email-assistgartner.comhttps://www.gartner.com/en/industries/healthcare-providersjoinpavilion.comhttps://www.joinpavilion.com/compensation-report⌬ Apply this in PULSE
Free CRM · Revenue IntelligenceAudit pipeline, score reps, ship the fixGross Profit CalculatorModel margin per deal, per rep, per territoryRep Scheduling MatrixProtect high-value selling timeDeep dive · related in the library
story-cannabis · revenue-fixHow'd you fix Story Cannabis' revenue issues in 2026?focus-financial-partners · revenue-fixHow'd you fix Focus Financial Partners' revenue issues in 2026?mindgrub · revenue-fixHow'd you fix Mindgrub's revenue issues in 2026?hawthorne-machinery · hawthorne-catHow'd you fix Hawthorne Machinery's revenue issues in 2026?precision-medicine-group · precisionaqHow'd you fix Precision Medicine Group's revenue issues in 2026?northcoast-asset-management · revenue-fixHow'd you fix NorthCoast Asset Management's revenue issues in 2026?keeper-security · revenue-fixHow'd you fix Keeper Security's revenue issues in 2026?proshares · revenue-fixHow'd you fix ProShares' revenue issues in 2026?scs-financial · revenue-fixHow'd you fix SCS Financial's revenue issues in 2026?accenture · infrastructure-capital-projectsHow'd you fix Accenture Infrastructure and Capital Projects' revenue issues in 2026?More from the library
sales-training · title-insurance-trainingTitle Insurance: Winning a Top-Producer Realtor's Referral Without Violating RESPA — a 60-Minute Sales Trainingfood-truck · mobile-foodHow do you start a food truck business in 2027?upholstery-cleaning · carpet-cleaningHow do you start an upholstery cleaning business in 2027?mini-golf · putt-puttHow do you start a mini-golf venue business in 2027?revops · sales-compWhen should a founder-led company formalize sales comp and quotas, and does the timing change if you're documenting a playbook vs staying artisanal?window-tinting · automotive-servicesHow do you start a window tinting business in 2027?CRO · chief-revenue-officerWhat AI tools should every Chief Revenue Officer actually deploy in their stack in 2027?pricing · negotiationHow should a founder separate healthy price negotiation from margin-eroding discounting — and what's the framework for knowing which battle to fight?biohazard-cleanup · crime-scene-cleanupHow do you start a biohazard and crime-scene cleanup business in 2027?pricing · revopsWhat's the right cadence for auditing whether your pricing model is still fit-for-purpose — annual, quarterly, or event-triggered — and how does that sync with comp planning cycles?no-code · agencyHow do you start a no-code agency business in 2027?revops · discount-governanceWhat's the right architecture for discount governance when a company spans both sales-led enterprise and PLG SMB motion — should they operate entirely separate approval chains or integrate them?revops · deal-deskWhat's the founder's role in setting the actual discount-policy numbers vs delegating to the CRO — and what happens when the CRO and founder disagree on risk tolerance?sales-training · msp-msa-renewal-trainingManaged IT Services (MSP) MSA Renewal Conversation: Surviving the Mid-Market Squeeze (2027) — a 60-Minute Sales Trainingrevops · discount-governanceHow should a founder-led or early-stage sales org set up initial discount governance bands before they have reliable churn/NRR data by segment — should they default to conservative enterprise-tight rules or flexible SMB-loose bands?